These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11247532)

  • 1. Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay.
    Roy D; Ducher F; Laumain A; Legendre JY
    Drug Dev Ind Pharm; 2001 Jan; 27(1):107-9. PubMed ID: 11247532
    [No Abstract]   [Full Text] [Related]  

  • 2. High throughput solubility determination with application to selection of compounds for fragment screening.
    Colclough N; Hunter A; Kenny PW; Kittlety RS; Lobedan L; Tam KY; Timms MA
    Bioorg Med Chem; 2008 Jul; 16(13):6611-6. PubMed ID: 18502135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader.
    Chen TM; Shen H; Zhu C
    Comb Chem High Throughput Screen; 2002 Nov; 5(7):575-81. PubMed ID: 12470271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New screening tools for lead compound identification.
    Sawyer TK
    Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a partially automated solubility screening (PASS) assay for early drug development.
    Alsenz J; Meister E; Haenel E
    J Pharm Sci; 2007 Jul; 96(7):1748-62. PubMed ID: 17238197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between in vitro drug dissolution and in vivo response.
    Langguth P; Marroum P
    Biopharm Drug Dispos; 2012 Oct; 33(7):347-8. PubMed ID: 22910968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Alelyunas YW; Empfield JR; McCarthy D; Spreen RC; Bui K; Pelosi-Kilby L; Shen C
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7312-6. PubMed ID: 21055935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly automated assay for determining the aqueous equilibrium solubility of drug discovery compounds.
    Wenlock MC; Austin RP; Potter T; Barton P
    J Lab Autom; 2011 Aug; 16(4):276-84. PubMed ID: 21764023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation.
    Somayaji MR; Das D; Przekwas AJ
    Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643
    [No Abstract]   [Full Text] [Related]  

  • 10. Combinatorial screening for specific drug solubilizers with switchable release profiles.
    Wieczorek S; Vigne S; Masini T; Ponader D; Hartmann L; Hirsch AK; Börner HG
    Macromol Biosci; 2015 Jan; 15(1):82-9. PubMed ID: 25557786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based activity space: smaller is better.
    Hesterkamp T; Whittaker M
    Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data reduction methods for application of fluorescence correlation spectroscopy to pharmaceutical drug discovery.
    Davis LM; Williams PE; Ball DA; Swift KM; Matayoshi ED
    Curr Pharm Biotechnol; 2003 Dec; 4(6):451-62. PubMed ID: 14683437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.
    Cheng A; Merz KM
    J Med Chem; 2003 Aug; 46(17):3572-80. PubMed ID: 12904062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.
    Liu H; Sabus C; Carter GT; Du C; Avdeef A; Tischler M
    Pharm Res; 2003 Nov; 20(11):1820-6. PubMed ID: 14661927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block copolymer micelles for nanomedicine.
    Li W; Feng SS; Guo Y
    Nanomedicine (Lond); 2012 Feb; 7(2):169-72. PubMed ID: 22339128
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of reliable aqueous solubility models and their application in druglike analysis.
    Wang J; Krudy G; Hou T; Zhang W; Holland G; Xu X
    J Chem Inf Model; 2007; 47(4):1395-404. PubMed ID: 17569522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-throughput crystallization in pharmaceutical research and development].
    Feng ZQ; Deng W; Guo ZR
    Yao Xue Xue Bao; 2005 Jun; 40(6):481-5. PubMed ID: 16144309
    [No Abstract]   [Full Text] [Related]  

  • 18. One- to four-dimensional kernels for virtual screening and the prediction of physical, chemical, and biological properties.
    Azencott CA; Ksikes A; Swamidass SJ; Chen JH; Ralaivola L; Baldi P
    J Chem Inf Model; 2007; 47(3):965-74. PubMed ID: 17338509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a high-throughput screening method for the detection of the excipient-mediated precipitation inhibition of poorly soluble drugs.
    Petruševska M; Urleb U; Peternel L
    Assay Drug Dev Technol; 2013 Mar; 11(2):117-29. PubMed ID: 23116459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragonomics: fragment-based drug discovery.
    Zartler ER; Shapiro MJ
    Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.